Pharmacokinetics and selectivity of aminolevulinic acid–induced porphyrin synthesis in patients with cervical intra‐epithelial neoplasia

Photodynamic therapy (PDT), due to its tumor selectivity, represents an alternative approach to diagnose and treat cervical intra‐epithelial neoplasia (CIN) without altering normal surrounding tissue. Our aim was to investigate the pharmacokinetics and the selectivity of 5‐aminolevulinic acid (5‐ALA)–induced porphyrin fluorescence after topical administration, to obtain basic clinical data for future diagnostic fluorescence imaging and PDT protocols for CIN. Twenty‐eight non‐pregnant women with a cytological diagnosis of low‐grade or high‐grade squamous intra‐epithelial lesions were included. An aqueous solution containing 3% 5‐ALA was topically applied 1 to 6 hrs prior to conization using a cervical cap. After excision, porphyrin‐induced fluorescence was quantified in dysplastic (n = 14) and normal epithelium (n = 28) by means of quantitative fluorescence microscopy. High values of porphyrin fluorescence were found in squamous epithelium between 150 and 450 min, with a maximum at 300 min following administration of 5‐ALA. Ratios of porphyrin fluorescence of dysplastic vs. surrounding normal epithelium were 1.3 and 1.21 for CIN 1 (n = 3) and CIN 2 (n = 3), respectively. In CIN 3 patients (n = 8), this ratio was 2.35; the best selectivity of 5‐ALA‐induced porphyrin fluorescence in CIN 3 lesions (ratio 3) was observed with a topical administration time of between 150 and 250 min. Our results demonstrate that patients with CIN 3 show higher 5‐ALA‐induced fluorescence compared with normal epithelium. The optimal administration time of topically applied 5‐ALA was between 3 and 4 hr. Our data suggest that topical ALA‐PDT and photodynamic diagnosis might be suitable for detecting CIN. Int. J. Cancer 78:310–314, 1998.© 1998 Wiley‐Liss, Inc.

[1]  J. Jordan,et al.  Complications of cone biopsy related to the dimensions of the cone and the influence of prior colposcopic assessment , 1985, British journal of obstetrics and gynaecology.

[2]  H. Kato,et al.  Photodynamic Therapy for Cancers: A Clinical Trial of Porfimer Sodium in Japan , 1993, Japanese journal of cancer research : Gann.

[3]  Q. Peng,et al.  5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.

[4]  H Stepp,et al.  Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. , 1996, The Journal of urology.

[5]  M Landthaler,et al.  Topical photodynamic therapy in dermatology. , 1996, Journal of photochemistry and photobiology. B, Biology.

[6]  M. Read,et al.  Pregnancy after cervical loop diathermy , 1991, The Lancet.

[7]  G. Kuhnle,et al.  In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster. , 1994, British Journal of Cancer.

[8]  H Stepp,et al.  Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.

[9]  J. Kennedy,et al.  Detection of Early Stages of Carcinogenesis in Adenomas of Murine Lung by 5‐Aminolevulinic Acid‐Induced Protoporphyrin IX Fluorescence , 1996, Photochemistry and photobiology.

[10]  H Koren,et al.  Photodynamic therapy in gynaecologic cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.

[11]  A. Parkinson,et al.  Alterations in expression of CYP1A1 and NADPH-cytochrome P450 reductase during lung tumor development in SWR/J mice. , 1996, Carcinogenesis.

[12]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[13]  B. Monk,et al.  Photodynamic therapy using topically applied dihematoporphyrin ether in the treatment of cervical intraepithelial neoplasia. , 1997, Gynecologic oncology.

[14]  J. Ferlay,et al.  Estimates of the worldwide incidence of eighteen major cancers in 1985 , 1993, International journal of cancer.

[15]  G. Buonaccorsi,et al.  Mucosal ablation using photodynamic therapy for the treatment of dysplasia: an experimental study in the normal rat stomach. , 1996, Gut.

[16]  R. Sroka,et al.  In vivo fluorescence kinetics of porphyrins following intravesical instillation of 5-aminolaevulinic acid in normal and tumour-bearing rat bladders. , 1997, Journal of photochemistry and photobiology. B, Biology.

[17]  H. Pass,et al.  Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.

[18]  H. S. de Bruijn,et al.  Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice. , 1996, British Journal of Cancer.

[19]  Z. Malik,et al.  A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model. , 1996, British Journal of Cancer.

[20]  F. Wierrani,et al.  Clinical effect of meso‐tetrahydroxyphenylchlorine based photodynamic therapy in recurrent carcinoma of the ovary: preliminary results , 1997, British journal of obstetrics and gynaecology.

[21]  J. Fraumeni,et al.  Recent trends in cervix uteri cancer , 1989, Cancer.

[22]  M W Berns,et al.  Photodynamic destruction of endometrial tissue with topical 5-aminolevulinic acid in rats and rabbits. , 1994, American journal of obstetrics and gynecology.